Showing results (51-60 of 93) with videos related to
Sort By:
Pageof 10
Translational Oncology|August 4, 2020
Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemiaLi-Yun Chen, Li-Qing Kang, Hai-Xia Zhou, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 23, 2013
[Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells]Ting Yang, Guang-Hua Chen, Sheng-Li Xue, et al.Zhonghua Nei Ke Za Zhi|August 24, 2013
[The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation]Xiao-Jin Wu, Jun He, De-Pei Wu, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 30, 2014
[Changes of ADAMTS13 activity and vWF antigen level in patients with acute myelogenous leukemia and their significance]Wen-Juan Zhang, Yue Han, Zhen-Ni Ma, et al.Zhonghua Nei Ke Za Zhi|November 26, 2013
[The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy]Ying-xin Sun, Ming-qing Zhu, Guang-sheng He, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[Establishment and characterization of a new human myeloid leukemia cell line SH-2]Hui-Ying Qiu, Yong-Quan Xue, Jun Zhang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2013
[The correlation of cytomegalovirus gB genotype with viral DNA load and treatment time in patients with CMV infection after hematopoietic stem cell transplantation]Xiao-jing Wu, Ying Wang, Zi-ling Zhu, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Efficacy and Safety of the Induction Therapy with Different Doses of Anthracyclines for Patients with Newly Diagnosed Acute Promyelocytic Leukemia]Ya-Xue Wu, Xiao-Hui Hu, Su-Ning Chen, et al.Frontiers in Immunology|September 15, 2022
Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapyWen-Jie Gong, Yan Qiu, Ming-Hao Li, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2003
[Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine]De-pei Wu, Xiao Ma, Ai-ning Sun, et al.Pageof 10